Delayed Hematologic Recovery in AML Patients After Induction Chemotherapy is Associated with Inferior Relapse-Free Survival and Persistence of Preleukemic Mutations

被引：0
|
作者：
Murphy, Tracy [1 ]
Zhou, Jinfeng [1 ]
Daher-Reyes, Georgina [1 ]
Gupta, Vikas [1 ]
McNamara, Caroline [1 ]
Minden, Mark [1 ]
Schimmer, Aaron [1 ]
Sibai, Hassan [1 ]
Yee, Karen [1 ]
Stockley, Tracy [1 ]
Kamel-Reid, Suzanne [1 ]
Maze, Dawn [1 ]
Bratman, Scott [1 ]
Schuh, Andre [1 ]
Tierens, Anne [1 ]
Chan, Steven [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
preleukemic mutations; residual disease; AML; acute myeloid leukemia;
D O I：
10.1016/j.clml.2019.07.113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-276
引用
收藏
页码：S229 / S230
页数：2
相关论文
共 50 条
  • [1] Delayed Hematologic Recovery in AML Patients after Induction Chemotherapy Is Associated with Inferior Relapse-Free Survival and Persistence of Preleukemic Mutations
    Murphy, Tracy
    Zou, Jinfeng
    Daher-Reyes, Georgina S.
    Gupta, Vikas
    McNamara, Caroline J.
    Minden, Mark D.
    Schimmer, Aaron D.
    Sibai, Hassan
    Yee, Karen W. L.
    Stockley, Tracy L.
    Kamel-Reid, Suzanne
    Maze, Dawn
    Bratman, Scott
    Schuh, Andre
    Chan, Steven M.
    [J]. BLOOD, 2018, 132
  • [2] Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML
    Murphy, Tracy
    Zou, Jinfeng
    Daher-Reyes, Georgina S.
    Arruda, Andrea
    Gupta, Vikas
    McNamara, Caroline J.
    Minden, Mark D.
    Schimmer, Aaron D.
    Sibai, Hassan
    Yee, Karen W. L.
    Korulla, Mariam
    Stockley, Tracy
    Kamel-Reid, Suzanne
    Maze, Dawn
    Tierens, Anne
    Bratman, Scott, V
    Schuh, Andre C.
    Chan, Steven M.
    [J]. BLOOD ADVANCES, 2019, 3 (15) : 2307 - 2311
  • [3] Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer
    Thomae, Keith
    Sargent
    Russell, Christy A.
    Russell
    [J]. AMERICAN JOURNAL OF SURGERY, 2022, 223 (03): : 543 - 543
  • [4] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY
    LINK, MP
    GOORIN, AM
    MISER, AW
    GREEN, AA
    PRATT, CB
    BELASCO, JB
    PRITCHARD, J
    MALPAS, JS
    BAKER, AR
    KIRKPATRICK, JA
    AYALA, AG
    SHUSTER, JJ
    ABELSON, HT
    SIMONE, JV
    VIETTI, TJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25): : 1600 - 1606
  • [5] PERSISTENCE OF PRELEUKEMIC CLONAL HEMATOPOIESIS AFTER CHEMOTHERAPY IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH HIGH RISK MDS AND AML
    Takahashi, K.
    Wang, F.
    Patel, K.
    Bueso-Ramos, C.
    Issa, G.
    Song, X.
    Zhang, J.
    Little, L.
    Gumbs, C.
    Ravandi, F.
    Kadia, T.
    Daver, N.
    Konopleva, M.
    Andreeff, M.
    Cortes, J.
    Garcia-Manero, G.
    Jabbour, E.
    Futreal, A.
    Kantarjian, H.
    [J]. LEUKEMIA RESEARCH, 2017, 55 : S17 - S18
  • [6] RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction Chemotherapy
    Ball, Brian J.
    Hsu, Meier
    Devlin, Sean M.
    Famulare, Christopher
    Cai, Sheng F.
    Dunbar, Andrew
    Epstein-Peterson, Zachary D.
    Menghrajani, Kamal
    Glass, Jacob L.
    Taylor, Justin
    Viny, Aaron D.
    Goldberg, Aaron D.
    Tallman, Martin S.
    Stein, Eytan M.
    [J]. BLOOD, 2019, 134
  • [7] Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia
    Yamazaki, Etsuko
    Kanamori, Heiwa
    Itabashi, Megumi
    Ogusa, Eriko
    Numata, Ayumi
    Yamamoto, Wataru
    Ito, Satomi
    Tachibana, Takayoshi
    Hagihara, Maki
    Matsumoto, Kenji
    Koharazawa, Hideyuki
    Taguchi, Jun
    Tomita, Naoto
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Fujisawa, Shin
    Ogawa, Koji
    Ishigatsubo, Yoshiaki
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 104 - 109
  • [8] Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia (AML) predicts superior relapse-free survival
    Elliott, Michelle A.
    Litzow, Mark R.
    Letendre, Louis
    Wolf, Robert C.
    Hanson, Curtis A.
    Tefferi, Ayalew
    Tallman, Martin S.
    [J]. BLOOD, 2007, 110 (11) : 547A - 547A
  • [9] Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center
    Sargent, Rachel E.
    Vazquez, Elizabeth
    Kang, Irene
    Lu, Janice
    Manchandia, Tejas
    Sheth, Pulin
    Terando, Alicia
    Nelson, Maria E.
    Carr, Azadeh
    Hong, David S.
    Sener, Stephen F.
    [J]. AMERICAN JOURNAL OF SURGERY, 2022, 223 (03): : 539 - 542
  • [10] Routine radiographic screening after completion of initial chemotherapy and relapse-free survival after transplant in patients with relapsed lymphoma
    Ganguly, Siddhartha
    McRae, Jennifer
    He, Jianghua
    Divine, Clint
    Abhyankar, Sunil
    Aljitawi, Omar
    McGuirk, Joseph P.
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (02) : 518 - 519
12345